| 摘要 |
The inventive antibody-based medication comprises an activated form of small or ultra-small doses of anti-interferon monoclonal, polyclonal or natural antibodies which are produced by repeated successive dilution and an external action, preferably using homeopathic technology. In order to produce antibodies, human or heterologous alpha, beta or gamma, including recombinant interferon is used, the mixture of different, mainly centesimal homeopathic dilutions being used. The inventive method for treating a pathological syndrome whose mechanisms of formation are influenced by the interferon action consists in using the activated forms of small or ultra-small doses of anti-interferon monoclonal, polyclonal, or natural antibodies, which are produced by repeated successive dilution and an external action. |
